News about

Merck Animal Health acquires leading data and analytics company, Quantified Ag to broaden livestock digital portfolio

Merck Animal Health, known as MSD Animal Health outside the United States and Canada, announced the completion of its acquisition of Quantified Ag, a leading data and analytics company that monitors cattle body temperature and movement in order to detect illness early

| 19/06/2020 | By |  332

Roche's IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone met one of its co-primary endpoints

Roche today announced that the phase III IPATential150 study met its co-primary endpoint of radiographic progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (mCRPC) and whose tumours had PTEN loss

| 19/06/2020 | By |  444

Neurocrine, Takeda collaborate to develop and commercialise potential therapies for psychiatric disorders

Neurocrine Biosciences Inc and Takeda Pharmaceutical Company Limited announced a strategic collaboration to develop and commercialise compounds in Takeda's early-to-mid-stage psychiatry pipeline. Specifically, Takeda granted an exclusive license to Neurocrine Biosciences for seven pipeline programmes, including three clinical stage assets

| 18/06/2020 | By |  216

FDA Issues Warning Letters to Companies Inappropriately Marketing Antibody Tests, Potentially Placing Public Health at Risk

The U.S. Food and Drug Administration has issued warning letters to three companies for marketing adulterated and misbranded COVID-19 antibody test

| 18/06/2020 | By |  468

App launched by Pharma cos to market products and educate doctors about new drugs in the wake of lockdown crisis

On the lines of the medical apps being used by healthcare professionals and chronic patients to avail information on medicines and doctors' services, the pharmaceutical manufacturing companies worldwide have started launching Pharma Apps to educate doctors and hospital administrators about new drugs

| 16/06/2020 | By |  350

Bayer extends clinical development program for finerenone with Phase III study in patients with heart failure and preserved ejection fraction

Bayer announced today the initiation of the FINEARTS-HF study, a multicenter, randomized, double-blind, placebo-controlled Phase III study to evaluate the efficacy and safety of finerenone on morbidity and mortality in patients suffering from symptomatic heart failure

| 16/06/2020 | By |  586

FDA Approves Drug to Treat Infants and Children with HIV

Today, the U.S. Food and Drug Administration approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at least four weeks old and weighing at least 3 kg (6.61 pounds) in combination with other antiretroviral treatments

| 15/06/2020 | By |  412

Roche announces 2-year risdiplam data from SUNFISH and new data from JEWELFISH in infants, children and adults with spinal muscular atrophy (SMA)

Roche today presented two-year data from Part 1 of its pivotal SUNFISH trial in people aged 2-25 years with Type 2 or 3 spinal muscular atrophy (SMA) at the virtual Cure SMA Annual Conference, 8-12 June, 2020

| 15/06/2020 | By |  491

Cipla releases batch of 700 tocilizumab injections to Gujarat FDCA to address growing demand for treatment of COVID-19 patients

Following National Pharmaceutical Pricing Authority (NPPA) directive to address the demand of tocilizumab injection in government hospitals in Gujarat for the treatment of COVID-19 patients, the Mumbai-based pharmaceutical major Cipla Ltd has renewed its supply by releasing another batch of 700 tocilizumab injections to Gujarat

| 11/06/2020 | By |  976

FDA Authorizes First Next Generation Sequence Test for Diagnosing COVID-19

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Illumina, Inc. for the first COVID-19 diagnostic test utilizing next generation sequence technology

| 11/06/2020 | By |  814